The phenotype of SPG39 corresponds to SPG20, an AR form of HSP with lower motor neuron involvement, and to organophosphorous compound-induced delayed neuropathy (OPIDN) with distal axonal degeneration [8–10]. This evidence concerns the gene PNPLA6 and hereditary spastic paraplegia.